Huge underuse of germline testing for cancer patientsJune 22, 2023Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCellular Therapy
DEI training gives oncology fellows more confidenceJune 22, 2023Diversity in MedicineDLBCLALLAggressive LymphomasAMLB Cell LymphomaCLL
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Patient & Survivor CareDLBCLAggressive LymphomasALLAMLAnemiaB Cell Lymphoma
Widespread carboplatin, cisplatin shortages: NCCN surveyJune 9, 2023Patient & Survivor CareMixed TopicsAggressive LymphomasALLAMLB Cell LymphomaCLL
Cross-border U.S.-Mexican collaboration drives up ALL survivalJune 4, 2023ALLPatient & Survivor CarePediatricsDiversity in Medicine
ASCO honors Hagop Kantarjian, MD, for leukemia researchMay 16, 2023CMLALLAMLBusiness of MedicineMixed TopicsMyelodysplastic Syndrome
Number of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Patient & Survivor CareDiversity in MedicineMixed TopicsDLBCLALLAMLAnemia
75 years: A look back on the fascinating history of methotrexate and folate antagonistsJanuary 26, 2023PediatricsALL
